Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 2,213,242 | 1,969,058 | 1,775,423 | 1,601,892 | 1,485,807 |
| Cost of Goods | 971,700 | 871,676 | 799,987 | 711,622 | 669,691 |
| Gross Profit | 1,241,542 | 1,097,382 | 975,436 | 890,270 | 816,116 |
| Operating Expenses | 750,907 | 685,030 | 626,184 | 590,980 | 556,552 |
| Operating Income | 491,335 | 413,028 | 350,239 | 299,912 | 260,255 |
| Interest Expense | 34,744 | 37,225 | 32,049 | 29,239 | 15,429 |
| Other Income | 1,151 | 5,254 | 3,656 | 2,468 | 1,729 |
| Pre-tax Income | 457,742 | 381,057 | 321,846 | 273,141 | 246,555 |
| Income Tax | 80,695 | 117,788 | 99,792 | 81,006 | 64,604 |
| Net Income Continuous | 377,047 | 263,269 | 222,054 | 192,135 | 181,951 |
| Minority Interests | 16 | 125 | 9 | 57 | 45 |
| Net Income | $377,031 | $263,144 | $222,045 | $192,078 | $181,906 |
| EPS Basic Total Ops | 4.34 | 3.00 | 2.47 | 2.07 | 1.82 |
| EPS Basic Continuous Ops | 4.34 | 3.00 | 2.47 | 2.07 | 1.82 |
| EPS Diluted Total Ops | 4.26 | 2.94 | 2.44 | 2.05 | 1.79 |
| EPS Diluted Continuous Ops | 4.26 | 2.94 | 2.44 | 2.05 | 1.79 |
| EPS Diluted Before Non-Recurring Items | 4.26 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $574,513 | $496,168 | $429,300 | $370,300 | $319,143 |